Financial Performance

Assertio Holdings delists from Nasdaq after its merger with Zydus. A deep dive into the strategic calculus and the crucial decision facing its debt holders.

Biotech firm Azitra is leveraging its engineered microbe tech to tackle rare diseases and enter the $71B cosmeceutical market. Is this a brilliant pivot or a risky bet?

Why is an affordable housing nonprofit building a Hyatt? National CORE's $103M project is a masterclass in creative finance for social good.

Claro USA and reVolver Podcasts join forces to launch Claro Música Pulso, an all-in-one platform aiming to become the dominant entertainment hub for Hispanic audiences.

A company denies wrongdoing, but its stock's 'meme' status triggers a delisting. Jessica Campbell analyzes a new era of risk where online chatter can be fatal.

As its CFO prepares for a high-stakes J.P. Morgan conference, America's only integrated rare earth producer stands at the nexus of technology, finance, and geopolitics.

Opus Genetics unveils a multi-program gene therapy pipeline, backed by a robust financial runway, aiming to systematically dismantle inherited retinal diseases.

A new study validates iMDx's precision diagnostic tech, setting the stage for a strategic assault on the centralized lab model for organ rejection monitoring.

Verastem Oncology's new drug enters a pivotal trial for pancreatic cancer, targeting a notorious mutation with a novel dual-action mechanism.

Reitmans defies retail gloom with Q1 growth, proving strategic cost-cutting and revitalized brick-and-mortar stores can forge a path to resilience.

The insurer's expansion isn't just about a new state. It's a strategic fusion of InsurTech speed and century-old underwriting to tackle complex risks.

A federal court sided with marine marketplace giant Boats Group, dismissing an antitrust suit. We deconstruct the ruling and what it means for tech titans.

We're all ignoring unknown calls. A new report sheds light on why, revealing a deep-seated digital caution that is creating a multi-billion dollar market for trust.

A $1.2M seed round for orthopaedic AI firm Maia isn't just startup news. It signals a systemic shift from generalist AI to specialized digital engines.

A new alliance between Sun Life and Medzown moves beyond financial safety nets, using AI to steer patients to clinical trials and reshape corporate healthcare.

A new class-action lawsuit alleges Microsoft misled investors on its AI success. We dissect the claims, the market fallout, and the high-stakes game of AI.

Mastercard's $10,000 grants are just the headline. The real story is the ecosystem it's building to fix a broken funding model for women entrepreneurs.

An audit reveals critical weaknesses in how some BC school districts spend public money, putting millions at risk and raising questions about fairness and value.

New appointments bring deep legal and pharma expertise to Canada's Patented Medicine Prices Review Board, signaling a pivotal moment under new 2026 guidelines.

The SBA invites small businesses to pledge allegiance to American enterprise for the nation's 250th. But is it a patriotic honor or a political tool?